Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Experimental research in GHK-Cu indicates the peptide may host the potential to impact tissue repair and affect certain immunological functions
Pharmacokinetically, BPC-157 has a relatively short plasma half-life estimated at 10-15 minutes when administered parenterally, though its tissue-level effects persist far longer due to receptor-level interactions and growth factor cascading
Researchers have tested it in animals for its regenerative effects
By fostering these reparative processes, BPC-157 Peptides facilitate enhanced mobility and performance optimization
Download COA here:DSIP
Aging pathobiology and therapeutics, 2(1), 58
US$ 27.56
US$ 23.71
US$ 26.82
